COMMUNIQUÉS West-GlobeNewswire

MDxHealth Provides First Quarter 2018

24/04/2018 - 07:01

NEWS RELEASE REGULATED INFORMATION INTERIM TRADING UPDATE MDxHealth Provides First Quarter 2018 Business Update IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, April 24, 2018 - MDxHealth SA ("MDxHealth, or the "Company [...]

MDxHealth publie ses résultats du premier trimestre 2018

24/04/2018 - 07:01

COMMUNIQUÉ DE PRESSE INFORMATIONS REGLEMENTÉES RAPPORT D'ACTIVITÉS TEMPORAIRE MDxHealth publie ses résultats du premier trimestre 2018 IRVINE, CA, et HERSTAL, BELGIQUE - 07h00 CEST, mardi 24 avril 2018 - MDxHealth SA [...]

argenx to present complete data from the Phase 2 proof-of-concept trial of efgartigimod (ARGX-113) in generalized myasthenia gravis at American Academy of Neurology (AAN) Annual Meeting

24/04/2018 - 07:01

Eight-week follow-up data show separation of clinical efficacy scores between treatment group and placebo group through the duration of study Total and pathogenic IgG reduction correlates with disease score improvements [...]

Axiom Real-Time Metrics Exhibiting Fusion eClinical Suite at Clinical Operations in Oncology Trials West

24/04/2018 - 01:11

TORONTO, April 23, 2018 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics, premier provider of unified eClinical solutions and services, is exhibiting at Clinical Operations in Oncology Trials West on April 24 th and 25 th in [...]

Immuron CEO to Present at RedChip Global Online Growth Conference

24/04/2018 - 00:57

MELBOURNE, Australia, April 23, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ: IMRN ), Australian microbiome biopharmaceutical company focused on developing and commercialising orally delivered targeted [...]

Apellis Pharmaceuticals Announces Closing of Offering of Common Stock

24/04/2018 - 00:20

CRESTWOOD, Ky. and WALTHAM, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds [...]

Epizyme Provides Update Regarding Tazemetostat Clinical Program

23/04/2018 - 22:45

CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ: EPZM ), a clinical-stage company developing novel epigenetic therapies, today announced that U.S.-based enrollment of new patients into [...]

Surface Oncology Announces Closing of $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement

23/04/2018 - 22:30

CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Surface Oncology, Inc. (“Surface”), an immuno-oncology company developing next-generation antibody therapies that target the tumor microenvironment, today announced [...]

Brian Andrews to Succeed Albert White as Chief Financial Officer of The Cooper Companies

23/04/2018 - 22:17

PLEASANTON, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced that Brian Andrews has been promoted to Senior Vice President, Chief Financial Officer and Treasurer of The [...]

Natus Confirms Receipt of Notice of Voce Capital’s Intent to Nominate Director Candidates to Replace 50% of the Natus Board

23/04/2018 - 22:11

No Shareholder Action Required at this Time PLEASANTON, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) (“Natus” or the “Company”) today confirmed that Voce Capital Management LLC [...]

Genesis HealthCare Sells 51% Stake in Chinese Subsidiary GRS-HS to Riswein Health Industry Investment Co., Ltd

23/04/2018 - 22:05

KENNETT SQUARE, Pa., April 23, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (Genesis, or the Company) (NYSE: GEN ), one of the largest post-acute care providers in the United States, today announced that it has signed a [...]

Harvard Bioscience Schedules First Quarter 2018 Conference Call for May 2 at 4:30 PM ET

23/04/2018 - 22:05

HOLLISTON, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO ), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results [...]

ChromaDex Appoints Frank Jaksch As Executive Chairman, Rob Fried as Chief Executive Officer and Kurt Gustafson as Lead Director

23/04/2018 - 22:05

New Management Structure Further Fuels Strategic Evolution into Consumer-Focused Integrated Nutraceutical Company IRVINE, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), an integrated, [...]

Tivity Health Reports First-Quarter 2018 Results and Affirms Financial Guidance

23/04/2018 - 22:05

REVENUES OF $150 MILLION AND DILUTED EPS OF $0.49 ANNOUNCES HIRING OF CHIEF BRAND OFFICER NASHVILLE, Tenn., April 23, 2018 (GLOBE NEWSWIRE) -- Tivity Health, Inc. (NASDAQ: TVTY ) today announced financial results for [...]

Avadim Technologies Receives Notices of Allowance From U.S. and Japan Patent Offices for Inventions Related to Reducing Catheter Associated Urinary Tract Infections (CAUTI)

23/04/2018 - 22:02

ASHEVILLE, N.C., April 23, 2018 (GLOBE NEWSWIRE) -- Avadim Technologies, Inc. (“Avadim”), the Bionome Therapies TM life sciences company, announced today that its patent applications have been allowed in the U.S. and [...]

Adventist Health and St. Joseph Health Announce Formation of a New Joint Operating Company

23/04/2018 - 22:02

Affiliation will expand access to quality care in Humboldt, Mendocino, Lake, Sonoma, Napa and Solano counties SANTA ROSA, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Adventist Health and St. Joseph Health announced an [...]

Optinose CEO Peter Miller and President/COO Ramy Mahmoud Named EY Entrepreneur of the Year 2018 Finalists in the Greater Philadelphia Area

23/04/2018 - 22:01

YARDLEY, Pa., April 23, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that CEO Peter [...]

Nuvectra™ to Report First Quarter 2018 Financial Results on May 2, 2018

23/04/2018 - 22:01

PLANO, Texas, April 23, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today that it will release its financial results for the first quarter ended [...]

Nohla Therapeutics Announces Hiring of Gary Christianson as Chief Operating Officer

23/04/2018 - 22:00

Mr. Christianson Brings More Than 30 Years of Commercial and Operational Expertise SEATTLE, April 23, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a clinical stage biopharmaceutical company focused on the [...]